Riskpilot← Back to searchSign inGet full accessBokans AB
ABActiveOrg 5593107914Hörlanders Väg 15General medical practice activities · NACE 8621Est. 20211-4 employees
Revenue 2025
SEK 85K
EBITDA margin
8.8%
+109% vs 2024
Equity ratio
84.6%
Financial strength
Net profit 2025
SEK 326K
+4571% vs 2024
| Revenue | SEK 85K | — |
| EBITDA | SEK 7K | +109% |
| Net profit | SEK 326K | +4571% |
| Total assets | SEK 1,7M | -12% |
| Equity | SEK 1,4M | -8% |
| Employees | — | — |
Legal name
Bokans AB
Org number
5593107914
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
7 april 2021
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Verksamheten består av läkarpraktik, företagshälsovård, rehabilitering, konsultverksamhet och utbildning inom medicin och sjukvård, ävensom organisations-, ledarskaps- och medarbetarutveckling och därmed förenlig verksamhet. Även handel med fast och lös egendom och liknande verksamhet.
Address
Hörlanders Väg 15
Email
bokan.barazanji@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 456 | 1 187 | 1 157 | 0 | 85 |
| Staff expenses | — | −22 | −39 | −0 | −0 |
| EBITDA | 353 | 960 | 957 | −82 | 7 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 353 | 960 | 957 | −82 | 7 |
| Net financials | — | 1 | 13 | 25 | 322 |
| Profit before tax | 353 | 961 | 730 | −7 | 329 |
| Tax | −73 | −188 | −152 | — | −3 |
| Net profit | 280 | 773 | 578 | −7 | 326 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 461 | 1 534 | 2 456 | 1 879 | 1 655 |
| Equity | 330 | 1 103 | 1 681 | 1 524 | 1 400 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 131 | 431 | 535 | 166 | 65 |
| Total debt | 131 | 431 | 535 | 166 | 65 |
EBITDA margin
8.8%
This company
15.8%
Market median
-44% vs market
20212025
Equity ratio
84.6%
This company
38.2%
Market median
+121% vs market
20212025
Return on equity
23.3%
This company
18.4%
Market median
+27% vs market
20212025
Net profit margin
383.7%
This company
8.1%
Market median
+4637% vs market
20212025
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
20212025
Debt / equity
0.18×
This company
0.62×
Market median
+71% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-04-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Bokans AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Magdalena Elzbieta Przywozna | Deputy Board Member | 0 companies |
| Bokan Barazanji | Board of Directors | 0 companies |